
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11602568
[patent_doc_number] => 20170119868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 15/393092
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18038
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393092 | ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN | Dec 27, 2016 | Abandoned |
Array
(
[id] => 16383202
[patent_doc_number] => 10808024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
[patent_app_type] => utility
[patent_app_number] => 16/064790
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 13
[patent_no_of_words] => 15837
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064790
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064790 | Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins | Dec 20, 2016 | Issued |
Array
(
[id] => 11881880
[patent_doc_number] => 09753045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Automated selection of microorganisms and identification using MALDI'
[patent_app_type] => utility
[patent_app_number] => 15/383573
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15041
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 711
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383573
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383573 | Automated selection of microorganisms and identification using MALDI | Dec 18, 2016 | Issued |
Array
(
[id] => 13618777
[patent_doc_number] => 20180360940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => LISTERIA-BASED IMMUNOTHERAPY AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/782023
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782023
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782023 | LISTERIA-BASED IMMUNOTHERAPY AND METHODS OF USE THEREOF | Dec 15, 2016 | Abandoned |
Array
(
[id] => 13622091
[patent_doc_number] => 20180362597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => Novel Proteins from Anaerobic Fungi and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 15/782016
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782016
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782016 | Proteins from anaerobic fungi and uses thereof | Dec 7, 2016 | Issued |
Array
(
[id] => 12210980
[patent_doc_number] => 09907771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Saponified tall oil fatty acid for use in treatment and animal feed supplements and compositions'
[patent_app_type] => utility
[patent_app_number] => 15/371442
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 4207
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15371442
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/371442 | Saponified tall oil fatty acid for use in treatment and animal feed supplements and compositions | Dec 6, 2016 | Issued |
Array
(
[id] => 11497856
[patent_doc_number] => 20170072041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'EHRLICHIAL INVASIN FOR IMMUNIZTION, DIAGNOSIS, AND CELL DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/362137
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19339
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15362137
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/362137 | Ehrlichial invasin for immunization, diagnosis, and cell delivery | Nov 27, 2016 | Issued |
Array
(
[id] => 11497991
[patent_doc_number] => 20170072176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'SYSTEMS AND METHODS FOR DELIVERY OF A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/358187
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358187 | Systems and methods for delivery of a therapeutic agent | Nov 21, 2016 | Issued |
Array
(
[id] => 13853781
[patent_doc_number] => 10188596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Omega-7 fatty acid composition, methods of cultivation of tribonema for production of composition and application of composition
[patent_app_type] => utility
[patent_app_number] => 15/535675
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6808
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535675 | Omega-7 fatty acid composition, methods of cultivation of tribonema for production of composition and application of composition | Nov 20, 2016 | Issued |
Array
(
[id] => 11809073
[patent_doc_number] => 09713631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'Method of identifying a biologically-active composition from a biofilm'
[patent_app_type] => utility
[patent_app_number] => 15/349420
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15415
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349420 | Method of identifying a biologically-active composition from a biofilm | Nov 10, 2016 | Issued |
Array
(
[id] => 11813831
[patent_doc_number] => 09717765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Method of identifying a biologically-active composition from a biofilm'
[patent_app_type] => utility
[patent_app_number] => 15/349371
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15413
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349371 | Method of identifying a biologically-active composition from a biofilm | Nov 10, 2016 | Issued |
Array
(
[id] => 13854009
[patent_doc_number] => 10188711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Peptide conjugated particles
[patent_app_type] => utility
[patent_app_number] => 15/341935
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 98
[patent_no_of_words] => 34087
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15341935
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/341935 | Peptide conjugated particles | Nov 1, 2016 | Issued |
Array
(
[id] => 11437353
[patent_doc_number] => 20170038374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'METHODS FOR ISOLATING A TARGET ANALYTE FROM A HETEROGENOUS SAMPLE'
[patent_app_type] => utility
[patent_app_number] => 15/332679
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14041
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332679 | Methods for isolating a target analyte from a heterogenous sample | Oct 23, 2016 | Issued |
Array
(
[id] => 12965020
[patent_doc_number] => 09874560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Rapid detection of the "high virulent" ST-17 clone of group B
[patent_app_type] => utility
[patent_app_number] => 15/291120
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 15501
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291120
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/291120 | Rapid detection of the "high virulent" ST-17 clone of group B | Oct 11, 2016 | Issued |
Array
(
[id] => 11542634
[patent_doc_number] => 20170096458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'CYAA-BASED CHIMERIC PROTEINS COMPRISING A HETEROLOGOUS POLYPEPTIDE AND THEIR USES IN THE INDUCTION OF IMMUNE RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 15/291517
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31581
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/291517 | CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses | Oct 11, 2016 | Issued |
Array
(
[id] => 12254214
[patent_doc_number] => 09926350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Targeting of chondroitin sulfate glycans'
[patent_app_type] => utility
[patent_app_number] => 15/285956
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36358
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285956
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285956 | Targeting of chondroitin sulfate glycans | Oct 4, 2016 | Issued |
Array
(
[id] => 11514300
[patent_doc_number] => 20170081373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'TARGETING OF CHONDROITIN SULFATE GLYCANS'
[patent_app_type] => utility
[patent_app_number] => 15/285830
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36364
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285830
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285830 | Targeting of chondroitin sulfate glycans | Oct 4, 2016 | Issued |
Array
(
[id] => 13490231
[patent_doc_number] => 20180296658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/763967
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -274
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763967
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763967 | Methods of treating and diagnosing disease using biomarkers for BCG therapy | Sep 28, 2016 | Issued |
Array
(
[id] => 11514597
[patent_doc_number] => 20170081671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'TUMOR ASSOCIATED VACCINES AND COMPOSITIONS FOR DISRUPTING TUMOR-DERIVED IMMUNOSUPPRESSION FOR USE IN COMBINATION CANCER IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/276645
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 34703
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276645 | Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy | Sep 25, 2016 | Issued |
Array
(
[id] => 11851702
[patent_doc_number] => 20170226194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/270461
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27725
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15270461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/270461 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Sep 19, 2016 | Issued |